Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,410 | 289 | 95.5% |
| Education | $208.48 | 17 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $545.70 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $437.03 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $299.19 | 37 | $0 (2023) |
| Novo Nordisk Inc | $285.41 | 23 | $0 (2024) |
| PFIZER INC. | $265.10 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $262.50 | 12 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $256.64 | 17 | $0 (2022) |
| GlaxoSmithKline, LLC. | $254.04 | 14 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $198.97 | 30 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $179.04 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $896.41 | 54 | Amgen Inc. ($203.21) |
| 2023 | $1,056 | 59 | Amgen Inc. ($215.55) |
| 2022 | $944.28 | 59 | SANOFI-AVENTIS U.S. LLC ($163.20) |
| 2021 | $400.60 | 32 | Janssen Pharmaceuticals, Inc ($131.25) |
| 2020 | $141.29 | 7 | Allergan, Inc. ($50.86) |
| 2019 | $285.81 | 18 | Lilly USA, LLC ($28.25) |
| 2018 | $371.83 | 12 | AstraZeneca Pharmaceuticals LP ($190.57) |
| 2017 | $522.63 | 65 | Merck Sharp & Dohme Corporation ($180.07) |
All Payment Transactions
306 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: Obesity | ||||||
| 11/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Diabetes Care | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: PAIN | ||||||
| 11/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: Obesity | ||||||
| 10/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: VACCINES | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Oncology | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Inflammation | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Gastroenterology | ||||||
| 07/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,390 | 3,530 | $585,561 | $215,128 |
| 2022 | 27 | 2,093 | 4,585 | $682,311 | $264,655 |
| 2021 | 45 | 2,872 | 5,529 | $1.0M | $345,749 |
| 2020 | 40 | 3,148 | 5,759 | $1.1M | $325,293 |
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 575 | 2,043 | $465,048 | $164,559 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 76 | $23,327 | $9,904 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 131 | $20,105 | $7,391 | 36.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 31 | 33 | $13,596 | $6,906 | 50.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 78 | 78 | $5,999 | $5,594 | 93.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 143 | $13,845 | $5,522 | 39.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 82 | 82 | $3,209 | $2,517 | 78.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 44 | 52 | $7,766 | $2,029 | 26.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 24 | 39 | $5,624 | $1,832 | 32.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 25 | 42 | $4,975 | $1,748 | 35.1% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 15 | 200 | $7,004 | $1,684 | 24.0% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 13 | 17 | $3,414 | $1,398 | 40.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 40 | 41 | $1,653 | $1,087 | 65.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 33 | 205 | $3,167 | $861.00 | 27.2% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 17 | 17 | $875.50 | $695.64 | 79.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 92 | 170 | $1,870 | $576.80 | 30.8% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 16 | 17 | $963.05 | $232.12 | 24.1% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 17 | 19 | $489.25 | $180.88 | 37.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 33 | 38 | $978.50 | $147.72 | 15.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $591.22 | $126.50 | 21.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 16 | 33 | $441.87 | $105.93 | 24.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 28 | 40 | $618.00 | $31.32 | 5.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 627 | 2,251 | $512,395 | $182,349 | 35.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 247 | 252 | $19,148 | $17,053 | 89.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 162 | $24,862 | $9,139 | 36.8% |
About John Bausher, MD, PHD
John Bausher, MD, PHD is a Family Medicine healthcare provider based in Aberdeen, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033207824.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Bausher, MD, PHD has received a total of $4,618 in payments from pharmaceutical and medical device companies, with $896.41 received in 2024. These payments were reported across 306 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,410).
As a Medicare-enrolled provider, Bausher has provided services to 9,503 Medicare beneficiaries, totaling 19,403 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Aberdeen, WA
- Active Since 10/10/2006
- Last Updated 02/03/2026
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1033207824
Products in Payments
- Otezla (Drug) $521.75
- FARXIGA (Drug) $292.65
- XARELTO (Drug) $218.22
- JARDIANCE (Drug) $183.91
- Kerendia (Drug) $170.09
- TRELEGY ELLIPTA (Drug) $139.70
- TOUJEO (Biological) $131.69
- JANUVIA (Drug) $126.38
- ELIQUIS (Drug) $116.93
- QULIPTA (Drug) $107.61
- ENTRESTO (Drug) $101.83
- BREZTRI (Drug) $101.47
- Ozempic (Drug) $100.09
- TRULICITY (Drug) $97.88
- VOQUEZNA (Drug) $89.99
- VRAYLAR (Drug) $84.98
- VAXELIS (Biological) $82.53
- Wegovy (Drug) $81.82
- INVOKANA (Drug) $80.97
- LEQVIO (Drug) $77.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Aberdeen
Dr. Andrew Mrowiec, Md, MD
Family Medicine — Payments: $16,613
Dr. Gwenneth Cancino, M.d, M.D
Family Medicine — Payments: $7,345
Kalie Norberg, Cnp, CNP
Family Medicine — Payments: $1,814
Laura Hallak, Md, MD
Family Medicine — Payments: $1,387
Dr. Julian Brown, M. D, M. D
Family Medicine — Payments: $1,111
Donna Small, Md, MD
Family Medicine — Payments: $834.84